Current treatment of behavioral and cognitive symptoms of Parkinson's disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F19%3A00071228" target="_blank" >RIV/00159816:_____/19:00071228 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14740/19:00109578

Výsledek na webu

<a href="https://www.sciencedirect.com/science/article/pii/S1353802019300872?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1353802019300872?via%3Dihub</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.parkreldis.2019.02.042" target="_blank" >10.1016/j.parkreldis.2019.02.042</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Current treatment of behavioral and cognitive symptoms of Parkinson's disease

Popis výsledku v původním jazyce

Cognitive and behavioral symptoms are common in Parkinson&apos;s disease, may occur even in the prodromal stages of the disease, worsen with disease progression, and surpass motor symptoms as the major factors affecting patient quality of life and caregiver burden. The symptoms may be caused by the disease pathology or they may represent adverse effects of treatment, or both etiological factors may contribute. Although many of these symptoms are related to dopaminergic dysfunction or dopaminergic medication, other neurotransmitters are involved as well. Behavioral symptoms including impulse control disorders, apathy, psychosis, as well as mild cognitive impairment and dementia are reviewed with a special focus on current treatment approaches.

Název v anglickém jazyce

Current treatment of behavioral and cognitive symptoms of Parkinson's disease

Popis výsledku anglicky

Cognitive and behavioral symptoms are common in Parkinson&apos;s disease, may occur even in the prodromal stages of the disease, worsen with disease progression, and surpass motor symptoms as the major factors affecting patient quality of life and caregiver burden. The symptoms may be caused by the disease pathology or they may represent adverse effects of treatment, or both etiological factors may contribute. Although many of these symptoms are related to dopaminergic dysfunction or dopaminergic medication, other neurotransmitters are involved as well. Behavioral symptoms including impulse control disorders, apathy, psychosis, as well as mild cognitive impairment and dementia are reviewed with a special focus on current treatment approaches.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30210 - Clinical neurology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Parkinsonism &amp; Related Disorders

ISSN

1353-8020

e-ISSN

—

Svazek periodika

59

Číslo periodika v rámci svazku

FEB 2019

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

65-73

Kód UT WoS článku

000468554700010

EID výsledku v databázi Scopus

2-s2.0-85063978978